• plus therapeutics (pstv) drops 4% as shares approach key support level - intraday trade ideas dars.gov.et Thu, 02 Jul 2026 19:35:28 GMT
• plus therapeutics | 4: statement of changes in beneficial ownership of securities-director hawkins richard j Moomoo Thu, 02 Jul 2026 01:36:57 GMT
• Plus Therapeutics (PSTV) CEO gains 16,439 shares from RSU vesting Stock Titan Wed, 01 Jul 2026 20:31:27 GMT
• PLUS Therapeutics (PSTV) director converts 922 RSUs into common stock Stock Titan Wed, 01 Jul 2026 20:31:24 GMT
• plus therapeutics (nasdaq: pstv) director gains 922 shares via rsu vesting Stock Titan Wed, 01 Jul 2026 20:31:04 GMT
• PLUS Therapeutics (PSTV) CFO converts RSUs into 2,985 common shares Stock Titan Wed, 01 Jul 2026 20:30:58 GMT
• [Form 4] PLUS THERAPEUTICS, INC. Insider Trading Activity Stock Titan Wed, 01 Jul 2026 20:30:57 GMT
• Plus Therapeutics rebrands as Cerenome as it deepens AI strategy Fierce Pharma Wed, 01 Jul 2026 11:24:09 GMT
• plus tx rebrands as cerenome as it deepens ai strategy Fierce Pharma Wed, 01 Jul 2026 11:24:09 GMT
• PLUS Therapeutics (PSTV) director converts RSUs into 922 common shares Stock Titan Wed, 01 Jul 2026 07:00:00 GMT
• plus therapeutics advances reyobiq clinical trials and manufacturing progress marketscreener.com Tue, 30 Jun 2026 13:43:28 GMT
• Plus Therapeutics rebrands as Cerenome, affirms 2026 milestones, and reports CNSide commercial progress Pluang Tue, 30 Jun 2026 11:49:28 GMT
• Plus Therapeutics rebrands as Cerenome, ticker CNSY starts Aug. 3 Stock Titan Tue, 30 Jun 2026 11:30:00 GMT
• from plus to cerenome: a new identity for an integrated cns cancer strategy BriefGlance Tue, 30 Jun 2026 11:30:00 GMT
• Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding Yahoo Finance Tue, 30 Jun 2026 07:00:00 GMT
• Plus Therapeutics to rebrand as Cerenome and adopt CNSY ticker on August 3 (PSTV) Yahoo Finance Tue, 30 Jun 2026 07:00:00 GMT
• Plus Therapeutics to rebrand as Cerenome, change ticker to CNSY Investing.com Tue, 30 Jun 2026 07:00:00 GMT
• Price to earnings forward of PLUS THERAPEUTICS, Inc. – NASDAQ:PSTV TradingView Tue, 30 Jun 2026 04:29:25 GMT
• Enterprise value to EBITDA forward of PLUS THERAPEUTICS, Inc. – NASDAQ:PSTV TradingView Mon, 29 Jun 2026 19:23:47 GMT
• Enterprise value to EBIT forward of PLUS THERAPEUTICS, Inc. – NASDAQ:PSTV TradingView Mon, 29 Jun 2026 19:11:59 GMT
• Price to book forward of PLUS THERAPEUTICS, Inc. – NASDAQ:PSTV TradingView Mon, 29 Jun 2026 18:53:48 GMT
• price to sales forward of plus therapeutics, inc. – nasdaq:pstv TradingView Mon, 29 Jun 2026 18:53:39 GMT
• Enterprise value to revenue forward of PLUS THERAPEUTICS, Inc. – NASDAQ:PSTV TradingView Mon, 29 Jun 2026 17:16:02 GMT
• Plus Therapeutics, Inc.(NasdaqCM: PSTV) added to Russell 3000E Growth Benchmark marketscreener.com Mon, 29 Jun 2026 03:51:41 GMT
• Plus Therapeutics, Inc.(NasdaqCM: PSTV) added to Russell Microcap Index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Plus Therapeutics, Inc.(NasdaqCM:PSTV) added to Russell Microcap Growth Benchmark Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• plus therapeutics, inc. actuals & estimates (gettex:xmp1) TradingView Fri, 26 Jun 2026 15:33:15 GMT
• plus therapeutics wins elevance coverage deal (pstv:nasdaq) Seeking Alpha Thu, 25 Jun 2026 12:02:32 GMT
• Plus Therapeutics Secures National Coverage Agreement with GlobeNewswire Thu, 25 Jun 2026 11:30:00 GMT
• Plus Therapeutics gets national health coverage for CNS cancer test Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Plus Therapeutics Subsidiary CNSide Diagnostics Signs National Coverage Agreement with Elevance Health for CNSide CSF Tumor Cell E... Quiver Quantitative Thu, 25 Jun 2026 07:00:00 GMT
• plus therapeutics to provide business update call on june 30, 2026 Sahm Wed, 24 Jun 2026 08:02:46 GMT
• Plus Therapeutics to Provide Business Update Call on June 30, 2026 GlobeNewswire Tue, 23 Jun 2026 11:30:00 GMT
• plus therapeutics to detail cnside launch, reyobiq plan june 30 Stock Titan Tue, 23 Jun 2026 11:30:00 GMT
• plus therapeutics inc (pstv) financial health: profitability & balance sheet analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• plus therapeutics inc (pstv) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• plus therapeutics inc (pstv) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 11:23:36 GMT
• plus therapeutics inc (pstv) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 11:23:34 GMT
• plus therapeutics inc (pstv) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 11:23:21 GMT
• plus therapeutics inc (pstv) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 11:23:10 GMT
• plus therapeutics inc (pstv) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 09:55:07 GMT
• plus therapeutics inc (pstv) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 06:19:14 GMT
• plus therapeutics inc (pstv) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• plus therapeutics inc (pstv) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• plus therapeutics inc (pstv) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• plus therapeutics inc annual shareholders meeting transcript GuruFocus Mon, 15 Jun 2026 03:18:53 GMT
• pstv maintained by ascendiant capital -- price target lowered to $57.00 GuruFocus Mon, 08 Jun 2026 13:52:30 GMT
• plus therapeutics launches new at-the-market equity program The Globe and Mail Sat, 06 Jun 2026 22:32:00 GMT
• plus therapeutics, inc. files form 8-k with sec detailing material definitive agreement – june 2026 minichart.com.sg Sat, 06 Jun 2026 14:38:00 GMT
• plus therapeutics launches $17.35 million atm equity program with canaccord genuity TradingView Fri, 05 Jun 2026 07:00:00 GMT
• plus therapeutics (nasdaq: pstv) sets $17,350,000 at-the-market stock program Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• plus therapeutics (pstv) adds form of indenture to s-3/a filing Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• cnside diagnostics receives laboratory accreditation from cap by investing.com Investing.com Nigeria Thu, 04 Jun 2026 11:56:00 GMT
• Plus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• Plus Therapeutics gains CAP accreditation for CNSide CSF assay platform Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• 'gold standard' cap seal backs u.s. rollout of cns cancer test Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• cnside diagnostics, a plus therapeutics subsidiary, achieves prestigious cap accreditation for clinical laboratory Quiver Quantitative Thu, 04 Jun 2026 07:00:00 GMT
• plus therapeutics - may offer and sell up to $100 million of securities from time to time - sec filing TradingView Tue, 02 Jun 2026 10:12:40 GMT
• plus therapeutics (nasdaq: pstv) launches $17.35m atm with canaccord Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• pstv stock price, quote & chart | plus therapeutics inc (nasdaq:pstv) ChartMill Tue, 02 Jun 2026 07:00:00 GMT
• plus therapeutics (nasdaq: pstv) launches $17.35m atm with canaccord Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• plus therapeutics secures fda orphan drug status for pediatric glioma treatment MSN Fri, 29 May 2026 03:45:50 GMT
• pstv stock on track for best week since september — here’s what is driving the rally MSN Thu, 28 May 2026 12:02:20 GMT
• plus therapeutics presents health economics study demonstrating substantial healthcare cost reduction with cnside diagnostic platf... marketscreener.com Tue, 26 May 2026 13:20:54 GMT
• Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases Yahoo Finance Tue, 26 May 2026 07:00:00 GMT
• new spinal fluid cancer test may cut $100k-a-month care costs ~40% Stock Titan Tue, 26 May 2026 07:00:00 GMT
• plus therapeutics showcases cnside's impact on early diagnosis and cost reduction at ispor annual meeting Quiver Quantitative Tue, 26 May 2026 07:00:00 GMT
• plus therapeutics (pstv) highlights economic benefits of early d GuruFocus Tue, 26 May 2026 07:00:00 GMT
• plus therapeutics study shows cnside may cut lm costs by 40% Investing.com Tue, 26 May 2026 07:00:00 GMT
• plus therapeutics secures fda orphan drug status for pediatric glioma treatment MSN Sun, 24 May 2026 09:25:38 GMT
• pstv technical analysis | trend, signals & chart patterns | plus therapeutics inc (nasdaq:pstv) ChartMill Fri, 22 May 2026 07:00:00 GMT
• maxim group maintains plus therapeutics(pstv.us) with buy rating, maintains target price $12 Moomoo Wed, 20 May 2026 15:32:00 GMT
• pstv stock price, quote & chart | plus therapeutics inc (nasdaq:pstv) ChartMill Wed, 20 May 2026 07:00:00 GMT
• net current asset value per share of plus therapeutics, inc. – dus:xmp1 TradingView Wed, 20 May 2026 02:53:44 GMT
• total common shares outstanding of plus therapeutics, inc. – dus:xmp1 TradingView Wed, 20 May 2026 02:53:42 GMT
• plus therapeutics stockholders back directors and incentive plan TipRanks Wed, 20 May 2026 00:42:31 GMT
• plus therapeutics (pstv) forms strategic alliance with ephemeral technologies GuruFocus Tue, 19 May 2026 21:22:52 GMT
• plus therapeutics, inc. - common stock (nq: pstv The Chronicle-Journal Tue, 19 May 2026 20:00:01 GMT
• plus therapeutics enters pact with ephemeral for ai execution platform TipRanks Tue, 19 May 2026 13:22:38 GMT
• Plus Therapeutics inks AI deal with Ephemeral Technologies AuntMinnie Tue, 19 May 2026 07:00:00 GMT
• Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology Yahoo Finance Tue, 19 May 2026 07:00:00 GMT
• plus therapeutics partners with ephemeral on ai platform Investing.com Tue, 19 May 2026 07:00:00 GMT
• lake street maintains plus therapeutics(pstv.us) with buy rating, maintains target price $50 Moomoo Tue, 19 May 2026 07:00:00 GMT
• ai team-up targets faster cns cancer treatments at plus therapeutics Stock Titan Tue, 19 May 2026 07:00:00 GMT
• plus therapeutics | 4: statement of changes in beneficial ownership of securities-director andrews ronald asbury - moomoo Moomoo Tue, 19 May 2026 02:58:39 GMT
• plus therapeutics secures fda orphan drug status for pediatric glioma treatment MSN Mon, 18 May 2026 12:35:35 GMT
• director at plus therapeutics (pstv) receives new equity awards Stock Titan Mon, 18 May 2026 07:00:00 GMT
• equity grants for plus therapeutics (pstv) director an van es-johansson Stock Titan Mon, 18 May 2026 07:00:00 GMT
• plus therapeutics (pstv) ceo receives new stock options and 23,834 rsus Stock Titan Mon, 18 May 2026 07:00:00 GMT
• plus therapeutics (pstv) cfo receives new stock options and rsu grants Stock Titan Mon, 18 May 2026 07:00:00 GMT
• plus therapeutics (pstv) director awarded new stock options and rsus Stock Titan Mon, 18 May 2026 07:00:00 GMT
• plus therapeutics (pstv) director receives new option and rsu awards Stock Titan Mon, 18 May 2026 07:00:00 GMT
• plus therapeutics (pstv) price target decreased by 72.34% to 38.76 MSN Mon, 18 May 2026 05:17:22 GMT
• headline news about plus therapeutics, inc. - common stock The Chronicle-Journal Sun, 17 May 2026 13:28:53 GMT
• plus therapeutics, inc. - common stock (nq: pstv The Chronicle-Journal Sun, 17 May 2026 11:24:16 GMT
• plus therapeutics stockholders back directors and incentive plan The Globe and Mail Sat, 16 May 2026 23:04:00 GMT
• plus therapeutics (pstv) price target decreased by 72.34% to 38.76 MSN Sat, 16 May 2026 19:12:11 GMT
• plus therapeutics reports q1 loss, raises $15m in offering Investing.com India Sat, 16 May 2026 02:15:00 GMT
• plus therapeutics (pstv) reports q1 revenue exceeding expectatio GuruFocus Sat, 16 May 2026 01:30:00 GMT
• plus therapeutics stockholders back directors and incentive plan TipRanks Fri, 15 May 2026 22:53:58 GMT
• pstv: net loss narrowed, cash declined, and future funding remains critical amid clinical and commercial progress TradingView Fri, 15 May 2026 20:39:09 GMT
• plus therapeutics (pstv) reports q1 revenue exceeding expectatio GuruFocus Fri, 15 May 2026 20:33:59 GMT
• plus therapeutics (pstv) q1 2026 loss highlights cash burn and going concern risk Stock Titan Fri, 15 May 2026 20:33:28 GMT
• plus therapeutics q1 loss narrows, revenue declines marketscreener.com Fri, 15 May 2026 20:18:14 GMT
• press release: plus therapeutics reports first quarter 2026 financial results and provides business update on reyobiq(tm) clinical... Moomoo Fri, 15 May 2026 20:05:00 GMT
• plus therapeutics 公佈了2026年第一季度財務業績，並提供了關於reyobiq臨床項目和cnside商業推廣的業務更新。 Moomoo Fri, 15 May 2026 20:05:00 GMT
• plus therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Fri, 15 May 2026 20:05:00 GMT
• all news about plus therapeutics, inc. - common stock The Chronicle-Journal Fri, 15 May 2026 20:00:01 GMT
• Plus Therapeutics (PSTV) Reports Q1 Loss, Tops Revenue Estimates Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• Plus Therapeutics Reports First Quarter 2026 Financial GlobeNewswire Fri, 15 May 2026 07:00:00 GMT
• FDA grants orphan tag to Plus brain cancer drug, CNS test covers 81M Stock Titan Fri, 15 May 2026 07:00:00 GMT
• BRIEF-Plus Therapeutics Q1 Net Income USD -6.946 Million TradingView Fri, 15 May 2026 07:00:00 GMT
• highbridge holds 7.1% stake in plus therapeutics (nasdaq: pstv) Stock Titan Fri, 15 May 2026 07:00:00 GMT
Plus Therapeutics(NASDAQ:PSTV) 
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system...
Website: https://www.plustherapeutics.com
Founded: 1996
Full Time Employees: 14
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends